What an inspiring two days at #ARU2025! Amazing science, thought‑provoking discussions, and plenty of new ideas to take back to the lab. We are already looking forward to the next one!"🪄
Thank you to @EMBLAustralia for the opportunity to take part in the annual PhD course this year! I had such a fun time networking and learning alongside the other students & researchers! 🔬🧪🥼👩🏽🔬
#EMBLAPhD
I was extremely fortunate to be able to present my work at @ESASRB@ReproductionSRB again. Such great work is happening in the reproductive field. I can't wait for next year!
Thank you to @ReproductionSRB@ESASRB for the opportunity to present this year! I’ve had the best time meeting and learning from other researchers 🥰 I can’t wait for the next meeting 👩🏽🔬❤️
Congratulations you our newest lab PhD graduate, @DrLaurenAlesi! Such a joy to work alongside you and watch your growth and development over the years, into a thriving postdoc 👩🎓 @KarlaHutt@amy_winship@JM_Stringer
In our 🆕 peer perspectives article we address 2 🔥 questions:
❄️ Is freezing gametes/tissue the only strategy to circumvent the harm of chemotherapy on the ovary?
💊 Are chemoprotective agents the future or fertility preservation?
🔗 academic.oup.com/humrep/adva…
Excited to share our new review (my first paper in Edinburgh!), online now in @TrendsMolecMed summarising recent advances with potential to accelerate diagnosis and improve care for endometriosis sciencedirect.com/science/ar…
An estimated 1 in 350 people carry germline BRCA1/2 mutations, which confer an increased risk of developing breast and ovarian cancer & may also contribute to subfertility.
Given the critical role of the BRCA proteins in mediating DNA repair, our data extend current knowledge of quality control mechanisms in the germline & lay foundations for future studies to test specific effects of genotoxic insults on oocytes in context of loss of BRCA1. 🧬
Together, our data demonstrate that BRCA1 is a key regulator of oocyte number and quality in females and suggest that caution should be used in relying on AMH as a reliable marker of the ovarian reserve in this context.